These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8869766)

  • 1. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain.
    Pascual J; del Arco C; Romón T; del Olmo E; Castro E; Pazos A
    Cephalalgia; 1996 Aug; 16(5):317-22. PubMed ID: 8869766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.
    Waeber C; Moskowitz MA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):263-75. PubMed ID: 8584041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord.
    Castro ME; Pascual J; Romón T; del Arco C; del Olmo E; Pazos A
    Neuropharmacology; 1997; 36(4-5):535-42. PubMed ID: 9225278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of [3H]-sumatriptan binding sites in human brain.
    Connor HE
    Cephalalgia; 1996 Aug; 16(5):287-8. PubMed ID: 8869759
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord.
    Mills A; Martin GR
    Eur J Pharmacol; 1995 Jul; 280(2):175-8. PubMed ID: 7589183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain.
    Lucaites VL; Krushinski JH; Schaus JM; Audia JE; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):178-84. PubMed ID: 15900511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
    McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
    Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1B receptor binding in degenerative movement disorders.
    Castro ME; Pascual J; Romón T; Berciano J; Figols J; Pazos A
    Brain Res; 1998 Apr; 790(1-2):323-8. PubMed ID: 9593971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors.
    Pascual J; Del Arco C; Romón T; Del Olmo E; Pazos A
    Eur J Pharmacol; 1996 Jan; 295(2-3):271-4. PubMed ID: 8720594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central sites of actions of zolmitriptan and sumatriptan: 5HT1B, 5HT1D and 5HT1F receptor distribution.
    Pascual J; Castro ME; Pazos A
    Cephalalgia; 1997 Oct; 17(6):711. PubMed ID: 9350394
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients.
    Pinessi L; Rainero I; Savi L; Valfrè W; Limone P; Calvelli P; Del Rizzo P; Gianotti L; Taliano M; Ghigo E; Arvat E
    Cephalalgia; 2000 May; 20(4):223-7. PubMed ID: 10999671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
    Stepień A; Chalimoniuk M; Strosznajder J
    Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache.
    Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L
    Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does sumatriptan cross the blood-brain barrier in animals and man?
    Tfelt-Hansen PC
    J Headache Pain; 2010 Feb; 11(1):5-12. PubMed ID: 20012125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
    Jeggo RD; Wang Y; Jordan D; Ramage AG
    Br J Pharmacol; 2007 Apr; 150(8):987-95. PubMed ID: 17339842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain stem activation in spontaneous human migraine attacks.
    Weiller C; May A; Limmroth V; Jüptner M; Kaube H; Schayck RV; Coenen HH; Diener HC
    Nat Med; 1995 Jul; 1(7):658-60. PubMed ID: 7585147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.